Search Results - "AV Susekov"

Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men by Watts, G.F, Chan, D.C, Barrett, P.H.R, Susekov, A.V, Hua, J, Song, S

“…Objective: To examine the association between the kinetics of very‐low‐density‐lipoprotein (VLDL)‐apolipoprotein B‐100 (apoB) and intraperitoneal,…”
Get full text

Practical aspects of "Heart Protection Studies" by Susekov, A V

Get more information

Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia by Susekov, A V

Get more information

Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia by Balakhonova, T V, Pogorelova, O A, Susekov, A V, Kobylianskiĭ, A G, Kuznetsova, T V, Tvorogova, M G, Masenko, V P, Titov, V N, Kukharchuk, V V, At'kov, O Iu

“…To study the influence of treatment with HMG-CoA reductase inhibitor atorvastatin on endothelial function in patients with familial hypercholesterolemia type…”
Get more information

Simvastatin in management of patients with primary hypercholesterolemia: tolerability and efficacy of daily doses 10-80 mg by Susekov, A V, Solov'eva, E Iu, Rozhkova, T A, Kotova, L A, Akhmedova, Z A, Kukharchuk, V V

“…To analyze retrospectively data on lipid lowering efficacy, tolerability and safety of different doses of simvastatin in patients with primary hyperlipidemia…”
Get more information

Lipanor treatment of atherogenic hyperlipoproteinemia by Susekov, A V, Tvorogova, M G, Arabidze, G G, Kukharchuk, V V

“…The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic hyperlipoproteinemia. The trial included 14…”
Get more information

Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia by Tvorogova, M G, Susekov, A V, Semenova, O A, Kukharchuk, V V, Titov, V N

“…To reveal the metabolic parameters of lipoproteins (L), which determine the benefits of hypolipidemic effects of simvastatin (S) and fluvastatin (F); to trace…”
Get more information

Slow release fluvastatin in the treatment of combined dyslipidemia in patients with ischemic heart disease. by Zubareva, M Iu, Susekov, A V, Rozhkova, T A, Solov'eva, E Iu, Kukharchuk, V V

Get more information

Case conference concerning 9-year-old boy having 20 mmol/lcholesterol: from diagnosis to effective treatment by AV Susekov, ZG Luginova, AN Meshkov, EY Solovyova, TV Balakhonova, MA Saidova, TI Kotkina, MY Scherbakova, VV Davydkin, MA Dubovenko, AY Postnov, ZB Khasanova, GA Konovalov, VV Kukharchuk

“…Familial hypercholesterolemia (FHC) is the most common and most severe form of monogenic dyslipidemia with early and rapidly progressing atherosclerosis and…”
Get full text

Lipoprotein (A) in patients with coronary atherosclerosis by Olofinskaia, I E, Volkova, E I, Susekov, A V, Liakishev, A A, Pokrovskiĭ, S N

“…The serum level of lipoprotein (a) (LP(a] was measured in 117 patients with coronary heart disease (CHD) angiographically documented, 22 patients with…”
Get more information

Use of immunosorption for selective decrease of lipoprotein (A) levels in patients with coronary atherosclerosis by Susekov, A V, Afanaséva, O I, Adamova, I Iu, Liakishev, A A, Kukharchuk, V V, Pokrovskiĭ, S N

“…Lipoprotein (a) [L(a)] is an atherogenic lipoprotein, its human plasma concentration correlates with the occurrence of coronary heart disease. The procedure…”
Get more information